DNMT3B and embryonal carcinoma: Interestingly, preclinical studies have found the nonseminoma embryonal carcinoma cells are hypersensitive to HMAs when used as single agents compared to somatic tumors that correlated with very high levels of the DNA methyltransferase, DNMT3B.23, 24, 25, 26, 27